ExoLab Italia is a biotechnological company that provides research, development and production of products.
ExoLab Italia has raised $5.2M in total funding. The most recent round was Series A. The last funding was announced in February 2025.
ExoLab Italia's investors include CDP Venture Capital, Maia Ventures, Riello Investimenti Partners, DSM-Firmenich Venturing.
ExoLab Italia is headquartered in L'aquila, Italy.
ExoLab Italia is a biotechnological company that provides research, development and production of products.
ExoLab Italia is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ExoLab Italia — Funding & Investors." VCBacked, February 18, 2025, https://www.vcbacked.co/company/exolab-italia. Accessed July 19, 2026.
VCBacked. (2025). ExoLab Italia — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/exolab-italia
{{cite web |title=ExoLab Italia — Funding & Investors |url=https://www.vcbacked.co/company/exolab-italia |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated